# Peptide Fundamentals, Without the Loose Ends > Peptide Quality FAQ — Research Peptide Fundamentals Research Peptides — Answers to common Research Peptide Fundamentals research peptides questions about BPC-157, retatrutide, GHK-Cu, tirzepatide, testing, and purity. **QUESTION LOG / TWELVE ANSWERS** Direct answers that separate mechanism, clinical evidence, anecdote, and analytical proof. ## What does “clean” mean for a research peptide? It means more than a high purity percentage. A defensible quality case addresses molecular identity, actual content, related impurities, biological contamination where relevant, and stability under stated conditions. Each claim needs a suitable method. A chromatogram cannot establish sterility, and a molecular-mass match cannot establish the amount in a vial. Traceability to the specific sample and lot is essential. ## What does BPC-157 do in the body? In experimental models, BPC-157 promotes angiogenesis and repair signaling through VEGFR2, Akt, and endothelial nitric-oxide synthase [4]. Rat work reports gastric-ulcer protection and healing effects [5]. Human efficacy is not established: a recent review found only three pilot human studies and no rigorous large-scale trials [2]. The accurate answer is therefore model-dependent, not a proven general effect in people. ## Is BPC-157 a growth hormone? No. BPC-157 is a fifteen-amino-acid peptide derived from a gastric protein sequence. Some experimental work links it to growth-hormone-receptor signaling in tendon fibroblasts, but interacting with a pathway does not make it growth hormone. Its better-described repair model involves vascular signaling through VEGFR2 [4]. ## Does BPC-157 work immediately? There is no controlled human efficacy dataset that can establish whether it works, much less a reliable onset. Community timelines are **anecdotal, not clinical evidence** and may involve unverified material. Animal pharmacokinetics show rapid breakdown, but pharmacokinetic speed does not prove rapid benefit [3]. ## What does retatrutide do? Retatrutide activates GIP, GLP-1, and glucagon receptors. In a forty-eight-week Phase 2 obesity trial, mean body-weight change reached -24.2% in the highest studied arm versus -2.1% with placebo [9]. A liver substudy also found large reductions in liver fat [8]. Those are investigational trial results; retatrutide is not approved [6]. ## How does retatrutide work? Its GIP and GLP-1 arms support glucose-dependent insulin signaling and reduce food intake, while glucagon-receptor activity is intended to add energy expenditure and lipid mobilization [6]. Structural research confirms engagement of all three receptors and shows that potency is not equal across them [7]. ## How is retatrutide reconstituted? This digest does not provide reconstitution or human-use instructions. Retatrutide is an investigational compound without an approved consumer product as of 2026 [6]. Outside a formal trial, identity, concentration, sterility, endotoxin status, compatibility, and stability may be unknown. Those uncertainties cannot be resolved by a generic mixing procedure. ## Is retatrutide FDA approved? No. Retatrutide remains investigational as of 2026, with its pivotal development program still relevant to long-term efficacy and safety [6]. Phase 2 findings are not an approval, and material sold outside trials is not an approved formulation. ## What is GHK-Cu and how does it work? GHK-Cu is a three-amino-acid peptide coordinated to copper(II). It acts as a copper carrier and influences fibroblast matrix production, antioxidant pathways, and gene expression [14][16]. Topical delivery is limited by poor passage through the outer skin layer, so formulation is part of the experimental result [13]. ## Is GHK-Cu peptide really anti-aging? “Anti-aging” is broader than the evidence. Small topical studies report changes in procollagen and skin measures, including procollagen responses in 70% of treated subjects in reviewed data [13]. Broader rejuvenation claims rely heavily on cell, animal, and gene-expression findings [14]. A careful conclusion is that topical signals exist, while sweeping whole-body claims are not established. ## What is the difference between GHK and GHK-Cu? GHK is the free tripeptide glycyl-histidyl-lysine. GHK-Cu is that peptide coordinated to a copper ion. The copper-bound state is central to much of the reported matrix and enzyme biology. A test that confirms the peptide sequence but ignores copper amount or coordination state does not fully characterize GHK-Cu. ## What is tirzepatide used for, and why does provenance matter? Tirzepatide is an approved dual GIP/GLP-1 receptor agonist used under regulated prescription indications [19]. Large trials studied obesity and type 2 diabetes outcomes [18][21][22]. Provenance matters because those findings attach to controlled formulations and protocols. An unrelated sample bearing the name is not validated by the trials; it needs its own identity, content, impurity, microbiological, and stability evidence. --- An independent analytical reading desk for peptide evidence and sample-quality risk—neither a laboratory certificate nor medical counsel.